Christine Winoto is Director of the Rosenman Institute, Deputy Director of QB3, Co-Founder and Venture Partner at MedTech Venture Partners I LLP, manages the QB3 Biotech/Biopharma Pitch Summit program, corporate partnership, and QB3 operations. Before joining QB3, she developed business plan and marketing strategy and capital planning for Kaiser Permanente and managed business development at Genencor. In addition to consulting for startups and venture capital, she has held R&D and operations positions in medical device companies including Physiometrix (IPO, then acquired by Hospira), Cardiovasc and Heartport. Christine also worked in mergers and acquisitions for a European investment bank. Christine holds an MBA from Erasmus University in the Netherlands and a BS in food chemistry from the University of Wisconsin, Madison.